SPAIN | ACTIS
06/11/2019
Lmite 14 Jul 2022
Oferta Tecnolgica
Ref.
TODE20210705003
A platform for discovering novel drug combinations through smarter data analysis
A European start-up has developed a proprietary biomedical data platform for better patient outcomes & acceleration of the development of novel treatment strategies for rare disease patients. The platform is designed to do this in a fraction of the time/cost of traditional drug development approaches. The platform focuses on clinical responder analyses, drug combinations & indication extensions. The company offers joint venture agreements, license agreements or research cooperation agreements.
Socios

logotipo CEOE Aragnlogotipo ITAINNOVAlogotipo Cmara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

06/11/2019

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019